EKQ-11389-41845
2 vaccinations
4 coded responses
22 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 170 / PA
- Registered
- 2021-06-06
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-06-05
Dose 1 — Pfizer-BioNTech
-
2021-06-06
Registered in v-safe
- 2021-06-06
- 2021-06-08
- 2021-06-09
- 2021-06-10
- 2021-06-11
- 2021-06-12
- 2021-06-19
-
2021-06-26
Dose 2 — Pfizer-BioNTech
- 2021-06-26
-
2021-06-27
Survey response — days 1–6 daily, dose 2MedDRA: Uterine contractions during pregnancy — Feeling: Good · Site: Pain, Swelling · Headache, Muscle or body achesFree text: Increased Braxton Hicks contractionsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-28
Survey response — days 1–6 daily, dose 2MedDRA: Condition aggravated, Pre-existing disease — Feeling: Poor · Site: Pain, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Continued increased frequency of Braxton Hicks contractionsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-06-29
- 2021-06-30
- 2021-07-01
- 2021-07-02
- 2021-07-03
- 2021-07-11
- 2021-07-17
- 2021-07-24
-
2021-08-02
Survey response — day 35, dose 2MedDRA: Unevaluable event — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · HospitalizationFree text: Symptoms: Gave birth · Healthcare visit (other): Planned hospitalization for laborMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-02
Report sent to call center — day 35, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
-
2021-08-04
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
- 2021-09-25
-
2021-12-25
Survey response — 6 months, dose 2MedDRA: Cough, Respiratory tract congestion, Sneezing — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Congestion, cough, sneezinfMedDRA releases: 2024-11 · check-in free text available
- 2022-06-28
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-06-05 | Pfizer-BioNTech | |
| 2 | 2021-06-26 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 9 — days 1–6 daily, dose 2
Systemic reaction (other): Increased Braxton Hicks contractions
Systemic reaction (other): Continued increased frequency of Braxton Hicks contractions
Release 9 — day 35, dose 2
Release 10 — 6 months, dose 2
Symptoms: Congestion, cough, sneezinf
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Unevaluable event | ✓ | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Sneezing | · | · | ✓ |
| SD | Unevaluable event | ✓ | · | ✓ |
| SRO | Condition aggravated | ✓ | ✓ | ✓ |
| SRO | Pre-existing disease | ✓ | ✓ | ✓ |
| SRO | Uterine contractions during pregnancy | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release